Hepion Pharmaceuticals, Inc.
PHARMACEUTICAL FORMULATIONS OF CYCLOSPORINE ANALOGS
Last updated:
Abstract:
The present disclosure relates to pharmaceutical compositions comprising CRV431 or a pharmaceutically acceptable salt thereof. The compositions exhibit high solubility and stability.
Status:
Application
Type:
Utility
Filling date:
22 Nov 2019
Issue date:
28 May 2020